Current Cancer Drug Targets
Home
Home
FOR AUTHORS
ARTICLES
SUBSCRIBERS & CORPORATES
CONTENTS & ABSTRACTS
CONTACT US
Wednesday, December 28, 2016
Most Accessed Article: Recent Advances in Site Specific Conjugations of Antibody Drug Conjugates (ADCs)
10:54 PM
No comments
Most Accessed Article: Recent Advances in Site Specific Conjugations of Antibody Drug Conjugates (ADCs)
Read More
Call For Paper
10:52 PM
No comments
Call For Paper
Read More
Wednesday, December 21, 2016
Free Trial Request
11:35 PM
No comments
Free Trial Request
Read More
Wednesday, December 14, 2016
Podcast for (Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies)
2:53 AM
No comments
Podcast for (Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies)
Read More
Thursday, December 8, 2016
Free Online Issue of Current Cancer Drug Targets
9:54 PM
No comments
Free Online Issue of Current Cancer Drug Targets
Read More
Tuesday, December 6, 2016
Issue Published Current Cancer Drug Targets Vol. 17 Issue 1
1:35 AM
No comments
Issue Published Current Cancer Drug Targets Vol. 17 Issue 1
Read More
← Newer Posts
Older Posts →
Home
Social Profiles
Blogroll
Popular
Tags
Blog Archives
New Issue Published Current Cancer Drug Targets Vol 18 issue 3
New Issue Published Current Cancer Drug Targets Vol 18 issue 3
New Issue Published Current Cancer Drug Targets Vol 17 issue 9
New Issue Published Current Cancer Drug Targets Vol 17 issue 9
Most Citied Article : Role of Inflammation-Associated Microenvironment in Tumorigenesis and Metastasis
Most Citied Article : Role of Inflammation-Associated Microenvironment in Tumorigenesis and Metastasis
Indian Authors have made substantial contributions to Bentham Science Journal Current Cancer Drug Targets
Indian Authors have made substantial contributions to Bentham Science Journal Current Cancer Drug Targets Journal Name: Current Canc...
Open Access Article : "HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of action, Clinical Activity, and Safety Profiles"
Open Access Article : "HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of action, Clinical Activity, and Safety Profile...
Call For Paper
Call For Paper
Cancer Stem Cells in Solid and Liquid Tissues of Breast Cancer Patients: Characterization and Therapeutic Perspectives
Author(s): Rena Chiotaki, Hara Polioudaki and Panayiotis A. TheodoropoulosPages 256-269 (14) Abstract: Breast cancer stem cells (BCSCs...
Highlighted Article: Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening
Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening Author(s): ...
(no title)
Cancer Stem Cells: Are We Targeting the Right Cells?
New Issue Published Current Cancer Drug Targets Vol 17 issue 7
New Issue Published Current Cancer Drug Targets Vol 17 issue 7
Blog Archive
►
2018
(3)
►
April
(1)
►
February
(1)
►
January
(1)
►
2017
(36)
►
December
(1)
►
October
(4)
►
September
(1)
►
August
(4)
►
July
(4)
►
June
(2)
►
May
(4)
►
April
(3)
►
March
(4)
►
February
(3)
►
January
(6)
▼
2016
(24)
▼
December
(6)
Most Accessed Article: Recent Advances in Site Spe...
Call For Paper
Free Trial Request
Podcast for (Targeting MDM4 as a Novel Therapeutic...
Free Online Issue of Current Cancer Drug Targets
Issue Published Current Cancer Drug Targets Vol. 1...
►
November
(4)
►
October
(8)
►
August
(1)
►
June
(5)
BTemplates.com
Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer
A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer
Cancer Stem Cells in Solid and Liquid Tissues of Breast Cancer Patients: Characterization and Therapeutic Perspectives
Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo
Pleiotropic Role of HSF1 in Neoplastic Transformation